Synthesis Analysis - A Robust Statistical Tool for Life Insurance Underwriting and Pricing Research
As life insurers move toward accelerated or low friction underwriting, there is an increased interest in adopting emerging mortality risk prediction scores that are available almost instantaneously.
The 2017 Clinical Practice Guidelines for Hypertension: What Underwriters Should Know
The American College of Cardiology and The American Heart Association published the new “2017 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults” on November 13, 2017. The new guidelines propose lower thresholds for diagnosing and lower goals for treating hypertension than the previous recommendations of 2003, especially for individuals at high risk for adverse future cardiovascular events.
Classification Model Performance (Gen Re Risk Insights)
Insurers are increasingly developing prediction models to use in their insurance processes. Often these models are using traditional techniques, but more and more we see machine learning techniques being applied.
Managing Risk and Assessing Opportunities: Modernizing Your Application Process
The time is right to "future-proof" underwriting processes. Let’s consider six key facts.
Heart Valve Diseases: How to Assess Risk & Manage Claims
In a new inFORM publication, SCOR Life division experts Dephine Labojka and Dr. James Kadouch discuss the most common heart valve diseases, their etiology, and the efficiency of surgery.
Thyroid Blood Testing: Which One Is Best For Which Condition?
Thyroid testing has become more sophisticated and much easier to interpret as the state of the art has progressed. Whereas much of the old testing required a reference test in addition in order to correct for different individual body protein status, newer testing is much more sensitive and spot-on as a single reported value. Each condition has one or two tests that make the best diagnosis as a primary test and tell the best story for diagnosis and treatment.
Insurance of the Future – Where are we Going?
What disruptive forces will insurers need to confront to compete? And what changes are already upon us? A summary of the changes afoot and the transformations ahead, from consumer engagement and underwriting to claims.
Rheumatoid Arthritis – Advances in Therapy
Rheumatoid Arthritis (RA) is an inflammatory autoimmune polyarthritis of unknown etiology that targets the synovial tissue of movable joints. It is a member of a class of rheumatic diseases with inflammatory arthritis as a primary symptom, but it may also affect other organs of the body.